News about Drug Discovery & Development

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

The product is the generic version of Bumex 1 Injection, 0.25 mg/mL, of Validus Pharmaceuticals

Drug Discovery & Development | 11/01/2023 | By Sudeep Soparkar 820

Zydus launches Topiramate extended-release capsules

Zydus launches Topiramate extended-release capsules

Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the US
<br />

Drug Discovery & Development | 07/01/2023 | By Sudeep Soparkar 831

Asymchem opens R&D site near Boston, Massachusetts

Asymchem opens R&D site near Boston, Massachusetts

The new Boston site is focussed on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development
<br />

Drug Discovery & Development | 20/12/2022 | By Sudeep Soparkar 859

Freudenberg Medical unveils HelixFlex at CPhI & PMEC India

Freudenberg Medical unveils HelixFlex at CPhI & PMEC India

TPE tubing is ideal for pharmaceutical bioprocessing applications

Drug Discovery & Development | 30/11/2022 | By Sudeep Soparkar 841

Cipla unveils Leuprolide Acetate Injection Depot 22.5mg

Cipla unveils Leuprolide Acetate Injection Depot 22.5mg

The injection is indicated for the palliative treatment of advanced prostate cancer

Drug Discovery & Development | 29/11/2022 | By Sudeep Soparkar 1046

NATCO Pharma launches Pomalyst caps in Australia

NATCO Pharma launches Pomalyst caps in Australia

The product was launched by NATCO’s commercial partner Juno Pharmaceuticals

Drug Discovery & Development | 09/11/2022 | By Sudeep Soparkar 1215

Glenmark launches Teneligliptin + Dapagliflozin Fixed-Dose Combination for adults with Type 2 diabetes

Glenmark launches Teneligliptin + Dapagliflozin Fixed-Dose Combination for adults with Type 2 diabetes

With this new launch, the company aims to improve glycemic control in adult patients with uncontrolled type 2 diabetes

Drug Discovery & Development | 21/10/2022 | By Sudeep Soparkar 692

Yapan Bio adds process development facility

Yapan Bio adds process development facility

Expands capacity and capabilities in large molecule therapeutics

Drug Discovery & Development | 19/10/2022 | By Sudeep Soparkar 837

Baxter Pharma opens global pharma R&D Centre in Ahmedabad

Baxter Pharma opens global pharma R&D Centre in Ahmedabad

The 20,500-square-foot, state-of-the-art R&D Centre features an array of sophisticated equipment and research labs that will focus on pharmaceutical product development

Drug Discovery & Development | 18/10/2022 | By Sudeep Soparkar 2854

Piramal Pharma Solutions launches ADCelerate

Piramal Pharma Solutions launches ADCelerate

ADCelerate is a new, branded solution for antibody-drug conjugate drug development

Drug Discovery & Development | 13/10/2022 | By Sudeep Soparkar 565

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members